(Q37122565)

English

Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases

scientific article published on 02 April 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

title

Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases (English)

1 reference

stated in

Europe PubMed Central

18 August 2017

0 references

postmenopausal osteoporosis

1 reference

Pierre D Delmas

1

1 reference

stated in

Europe PubMed Central

18 August 2017

2 April 2008

1 reference

stated in

Europe PubMed Central

18 August 2017

Journal of Clinical Densitometry

1 reference

stated in

Europe PubMed Central

18 August 2017

11

1 reference

stated in

Europe PubMed Central

18 August 2017

2

1 reference

stated in

Europe PubMed Central

18 August 2017

325-338

1 reference

stated in

Europe PubMed Central

18 August 2017

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1007/S00198-006-0172-4

Identifiers

DOI

10.1016/J.JOCD.2008.02.002

1 reference

stated in

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

PubMed ID

18375161

retrieved

18 August 2017

(Q37122565)

Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)